194 related articles for article (PubMed ID: 37386587)
1. The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells.
Wu YH; Huang YF; Wu PY; Chang TH; Huang SC; Chou CY
J Ovarian Res; 2023 Jun; 16(1):124. PubMed ID: 37386587
[TBL] [Abstract][Full Text] [Related]
2. The Downregulation of miR-509-3p Expression by Collagen Type XI Alpha 1-Regulated Hypermethylation Facilitates Cancer Progression and Chemoresistance via the DNA Methyltransferase 1/Small Ubiquitin-like Modifier-3 Axis in Ovarian Cancer Cells.
Wu YH; Huang YF; Wu PY; Chang TH; Huang SC; Chou CY
Res Sq; 2023 Feb; ():. PubMed ID: 36865240
[TBL] [Abstract][Full Text] [Related]
3. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells.
Wang Y; Yan C; Qi J; Liu C; Yu J; Wang H
Mol Cell Biochem; 2022 Jan; 477(1):307-317. PubMed ID: 34716858
[TBL] [Abstract][Full Text] [Related]
4. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
5. miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1.
Wu YH; Huang YF; Chang TH; Wu PY; Hsieh TY; Hsiao SY; Huang SC; Chou CY
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944877
[TBL] [Abstract][Full Text] [Related]
6. Activation of TWIST1 by COL11A1 promotes chemoresistance and inhibits apoptosis in ovarian cancer cells by modulating NF-κB-mediated IKKβ expression.
Wu YH; Huang YF; Chang TH; Chou CY
Int J Cancer; 2017 Dec; 141(11):2305-2317. PubMed ID: 28815582
[TBL] [Abstract][Full Text] [Related]
7. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization.
Wu YH; Chang TH; Huang YF; Chen CC; Chou CY
Oncotarget; 2015 Sep; 6(27):23748-63. PubMed ID: 26087191
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p.
Wang C; Qi S; Xie C; Li C; Wang P; Liu D
J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer.
Tian H; Yan L; Xiao-Fei L; Hai-Yan S; Juan C; Shan K
Clin Epigenetics; 2019 Oct; 11(1):153. PubMed ID: 31666131
[TBL] [Abstract][Full Text] [Related]
11. Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.
Li X; Pan Q; Wan X; Mao Y; Lu W; Xie X; Cheng X
BMC Cancer; 2015 Jul; 15():509. PubMed ID: 26152689
[TBL] [Abstract][Full Text] [Related]
12. Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells.
Luo Y; Gui R
J Gynecol Oncol; 2020 Sep; 31(5):e75. PubMed ID: 32808501
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
14. MiR-127-3p inhibits proliferation of ovarian cancer in rats through down-regulating MAPK4.
Du SY; Huang XX; Li NM; Lv CY; Lv CH; Wei ML; Gao Z; Zhang YP
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10383-10390. PubMed ID: 33155194
[TBL] [Abstract][Full Text] [Related]
15. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85.
Wu D; Lu P; Mi X; Miao J
Arch Gynecol Obstet; 2018 Mar; 297(3):699-707. PubMed ID: 29327155
[TBL] [Abstract][Full Text] [Related]
17. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
Gong YB; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S
Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR-155-5p.
Tong L; Ao Y; Zhang H; Wang K; Wang Y; Ma Q
Cancer Med; 2019 Aug; 8(10):4782-4791. PubMed ID: 31250987
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2.
Xia B; Lin M; Dong W; Chen H; Li B; Zhang X; Hou Y; Lou G
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22168. PubMed ID: 30004169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
